Weight loss drugs have minimal impact on Planet Fitness memberships

Summary

TD Cowen analyst report suggests that popular weight loss drugs like Wegovy and Zepbound are unlikely to negatively impact Planet Fitness memberships. A survey indicates that while many users do not expect changes in their physical activity, about 24% anticipate increased activity due to these drugs, and nearly half are either current gym members or intend to join. Currently, 24% of U.S. adults hold gym memberships, with a significant portion being young adults. The brokerage expects minimal impact on earnings as membership growth is supported by demographic trends and increased interest in weight training. Reuters

Impact Analysis

The event is classified at the company level as it directly pertains to Planet Fitness. The TD Cowen report highlights that despite the emergence of weight loss drugs, there is little expected impact on Planet Fitness’s membership growth and earnings. The direct effect is a reassurance for investors concerning potential threats from weight loss drugs. Second-order effects include sustained membership growth driven by demographic trends and a rising interest in weight training, which supports the company’s financial outlook. Investment opportunities may include maintaining or increasing positions in Planet Fitness stock, given the optimistic assessment and the stock’s target price being consistently revised upwards by analysts. Reuters+ 3